Transgene SA (GB:0OCQ)
LSE:0OCQ
Holding GB:0OCQ?
Track your performance easily

Transgene (0OCQ) Income Statement

2 Followers

Transgene Income Statement

Last quarter (Q4 2022), Transgene's total revenue was €―, a decrease of ― from the same quarter last year. In Q4, Transgene's net income was €―. See Transgene’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
-€ 3.13M€ 9.99M€ 2.98M€ 6.65M€ 1.33M
Cost of Revenue
------
Gross Profit
------
Operating Expense
-€ 33.25M€ 33.74M€ 27.31M€ 31.68M€ 28.58M
Operating Income
-€ -30.13M€ -23.75M€ -24.33M€ -25.02M€ -27.25M
Net Non Operating Interest Income Expense
-€ -3.32M€ 3.73M€ 6.68M€ 6.72M€ -2.15M
Other Income Expense
------
Pretax Income
-€ -32.80M€ -19.54M€ -17.23M€ -18.80M€ 8.03M
Tax Provision
-€ 0.00€ 0.00€ 0.00€ 0.00€ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-€ -32.80M€ -19.54M€ -17.23M€ -18.80M€ 8.03M
Basic EPS
-€ -0.33-€ -0.21€ -0.23€ 0.13
Diluted EPS
-€ -0.33-€ -0.21€ -0.23€ 0.13
Basic Average Shares
-€ 99.50M-€ 83.84M€ 83.27M€ 62.28M
Diluted Average Shares
-€ 99.50M-€ 83.84M€ 83.27M€ 62.28M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-€ 33.25M€ 33.74M€ 27.31M€ 31.68M€ 28.58M
Net Income From Continuing And Discontinued Operation
-€ -32.80M€ -19.54M€ -17.23M€ -18.80M€ 8.03M
Normalized Income
-€ -32.80M€ -19.53M€ -17.23M€ -18.80M€ 8.03M
Interest Expense
-€ 804.00K€ 464.00K€ 1.34M€ 1.44M-
EBIT
-€ -32.00M€ -19.07M€ -15.89M€ -17.36M€ -27.25M
EBITDA
-€ -30.31M€ -16.55M€ -14.11M€ -16.59M€ -25.04M
Currency in EUR

Transgene Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis